Rafferty Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,456,254
Closed -$913K 1249
2022
Q1
$913K Sell
1,456,254
-250,403
-15% -$193K 0.01% 797
2021
Q4
$1.89M Buy
1,706,657
+491,300
+40% +$759K 0.01% 681
2021
Q3
$2.25M Sell
1,215,357
-80,638
-6% -$181K 0.02% 603
2021
Q2
$4.11M Buy
+1,295,995
New +$3.24M 0.03% 384

Other funds holding ASXC

Rafferty Asset Management's ASXC Position: Q2 2022 in Review

Rafferty Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 1,456,254 shares — an estimated $913K sold.

Rafferty Asset Management first reported a position in ASXC in Q2 2021 and held it in 4 quarters. The position peaked at $4.11M in Q2 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Rafferty Asset Management reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 1,456,254 Asensus Surgical, Inc. shares in Q2 2022, an estimated $913K.
  • Rafferty Asset Management first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 4 quarters.
  • Rafferty Asset Management's Asensus Surgical, Inc. position peaked at $4.11M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.